Table 1 Descriptive data of the study group regarding age (years), sex, MTHFR gene mutation, smoking status, symptoms and their duration, and comorbidities
No. = 33 | ||
|---|---|---|
Age (years) | Mean ± SD | 45.42 ± 10.56 |
Range | 25–67 | |
Sex [No (%)] | Female | 14 (42.4%) |
Male | 19 (57.6%) | |
MTHFR gene mutation [No (%)] | Absent | 23 (69.7%) |
Heterozygous | 9 (27.3%) | |
Homozygous | 1 (3.0%) | |
Smoking [No (%)] | Non-smoker | 22 (66.7%) |
Smoker | 11 (33.3%) | |
Symptoms [No (%)] | ||
Fever | No | 14 (42.4%) |
Yes | 19 (57.6%) | |
Fatigue | No | 1 (3.0%) |
Yes | 32 (97.0%) | |
Bone ache | No | 3 (9.1%) |
Yes | 30 (90.9%) | |
Anosmia | No | 21 (63.6%) |
Yes | 12 (36.4%) | |
Nausea or vomiting | No | 17 (51.5%) |
Yes | 16 (48.5%) | |
Diarrhea | No | 21 (63.6%) |
Yes | 12 (36.4%) | |
Abdominal pain | No | 21 (63.6%) |
Yes | 12 (36.4%) | |
Sore throat | No | 21 (63.6%) |
Yes | 12 (36.4%) | |
Cough | No | 19 (57.6%) |
Yes | 14 (42.4%) | |
Dyspnea | No | 15 (45.5%) |
Yes | 18 (54.5%) | |
Co-morbidities [No (%)] | ||
Diabetes | No | 23 (69.7%) |
Yes | 10 (30.3%) | |
Hypertension | No | 27 (81.8%) |
Yes | 6 (18.2%) | |
Ischemic heart disease | No | 28 (84.8%) |
Yes | 5 (15.2%) | |
Chronic chest diseases | No | 29 (87.9%) |
Yes | 4 (12.1%) | |
Duration of symptoms (days) | Median (IQR) | 3 (3–4) |
Range | 1–14 | |